Search results
Japan's Takeda Pharma to restructure after annual profit slump
Reuters· 6 days ago, opens new tab announced a restructuring on Thursday after annual profit slid by more than half...
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss
The Wall Street Journal· 6 days agoThe Japanese drugmaker reported a fourth-quarter loss and forecast a drop in annual net profit due...
Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
Benzinga· 6 days agoOn Thursday, Japan’s drugmaker Takeda Pharmaceutical Company Limited TAK announced a restructuring...
Catalyst's New CEO Has Big Ideas For The Small Biotech
Investor's Business Daily· 5 days agoBut after cutting his teeth at Big Pharma stalwarts, including Takeda Pharmaceutical and...
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss
Morningstar· 6 days agoBy Kosaku Narioka Takeda Pharmaceutical reported a fourth-quarter loss and forecast a drop in annual net profit due partly to restructuring expenses. The ...
Scilex reaches settlement in patent lawsuit over Gloperba By Investing.com
Investing.com· 23 hours agoFederal Trade Commission and Department of Justice regarding its Settlement Agreement with Takeda ...
Takeda stock down 1% as operating profit declines
Investing.com· 7 days agoTakeda Pharmaceutical Company Limited (NYSE: TAK ) has surpassed its management guidance for revenue and core earnings per share (EPS) in fiscal year...
...s-Focused AC Immune Stock Trading Higher On Monday? - AC Immune (NASDAQ:ACIU), Takeda ...
Benzinga· 2 days agoMonday, Takeda Pharmaceutical Company Limited TAK and AC Immune SA ACIU announced an exclusive, worldwide option and license agreement for AC Immune’s active ...
AC Immunity Shares Soar on Exclusive License Deal with Takeda
Morningstar· 2 days agoBy Dean Seal Shares of AC Immunity surged after the company signed announced an agreement with Takeda Pharmaceutical for an exclusive option to license ...
Why Is AC Immune (ACIU) Stock Up 45% Today?
InvestorPlace· 2 days agoIncluded in that earnings report is an operational update that covers a new collaboration agreement with Takeda Pharmaceutical (NYSE:TAK). This has < ...